Fortress Biotech (FBIO) Cash from Investing Activities (2010 - 2025)

Fortress Biotech's Cash from Investing Activities history runs 15 years deep, the most recent figure standing at $2.9 million for Q3 2025.

• In Q3 2025, Cash from Investing Activities changed N/A year-over-year to $2.9 million; the TTM figure through Dec 2025 stood at $10.1 million (up 167.47% YoY), while the FY2025 annual figure was $10.1 million, up 167.47% from the prior year.
• Cash from Investing Activities for Q3 2025 stood at $2.9 million, down from $6.1 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $53.4 million in Q4 2021, with the low at -$21.3 million in Q1 2022.
• The 5-year median for Cash from Investing Activities is -$424500.0 (2021), against an average of $662750.0.
• The sharpest annual moves came in 2021 and 2024: Cash from Investing Activities soared 3504.79% in 2021, then slumped 23709.52% in 2024.
• Fortress Biotech's Cash from Investing Activities stood at $53.4 million in 2021, then sank by 100.73% to -$391000.0 in 2022, then soared by 83.89% to -$63000.0 in 2023, then plunged by 23709.52% to -$15.0 million in 2024, then jumped by 119.13% to $2.9 million in 2025.
• Business Quant data shows FBIO's Cash from Investing Activities at $2.9 million in Q3 2025, $6.1 million in Q2 2025, and $1.2 million in Q1 2025.